U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
GEPTANOLIMAB
INN  
Official Name English
GENOLIMZUMAB
INN  
Preferred Name English
Geptanolimab [WHO-DD]
Common Name English
geptanolimab [INN]
Common Name English
HUMANIZED IGG4 ANTIBODY DIRECTED AGAINST THE NEGATIVE IMMUNOREGULATORY HUMAN CELL SURFACE RECEPTOR PROGRAMMED CELL DEATH 1 (PD-1/PDCD1/PD1) WITH LOW ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY AND COMPLEMENT-DEPENDENT CYTOTOXICITY
Common Name English
CBT-501
Code English
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS PDCD1 (PROGRAMMED CELL DEATH 1, PD-1, PD1, CD279)), MONOCLONAL ANTIBODYGAMMA4 HEAVY CHAIN (1-440) (VH (HOMO SAPIENSIGHV7-4-1*02 (85.7%)-(IGHD)-IGHJ4*01 (100%)) CDR-IMGT (8.8.7) (26-33.51-58.97-103) (1-114)-HOMO
Common Name English
GB226
Code English
GB-226
Code English
MMUNOGLOBULIN G4 (232-PROLINE,DE-451-LYSINE), ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN-MUS MUSCULUS MONOCLONAL GB226 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL GB226 .KAPPA.-CHAIN, DIMER
Common Name English
APL-501
Code English
Code System Code Type Description
NCI_THESAURUS
C148159
Created by admin on Wed Apr 02 04:28:23 GMT 2025 , Edited by admin on Wed Apr 02 04:28:23 GMT 2025
PRIMARY
SMS_ID
300000024234
Created by admin on Wed Apr 02 04:28:23 GMT 2025 , Edited by admin on Wed Apr 02 04:28:23 GMT 2025
PRIMARY
CAS
2135810-45-4
Created by admin on Wed Apr 02 04:28:23 GMT 2025 , Edited by admin on Wed Apr 02 04:28:23 GMT 2025
NO STRUCTURE GIVEN
CAS
2348469-43-0
Created by admin on Wed Apr 02 04:28:23 GMT 2025 , Edited by admin on Wed Apr 02 04:28:23 GMT 2025
PRIMARY
FDA UNII
FME52R2SGN
Created by admin on Wed Apr 02 04:28:23 GMT 2025 , Edited by admin on Wed Apr 02 04:28:23 GMT 2025
PRIMARY
INN
11436
Created by admin on Wed Apr 02 04:28:23 GMT 2025 , Edited by admin on Wed Apr 02 04:28:23 GMT 2025
PRIMARY
ACTIVE MOIETY
GEPTANOLIMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966